Illumina Inc reports results for the quarter ended March 31 - Earnings Summary

• Illumina Inc ILMN.OQ reported quarterly adjusted earnings of 97 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 9 cents. The mean expectation of twenty two analysts for the quarter was for earnings of 94 cents per share. Wall Street expected results to range from 83 cents to 97 cents per share.

• Revenue fell 3.3% to $1.04 billion from a year ago; analysts expected $1.03 billion.

• Illumina Inc's reported EPS for the quarter was 82 cents​.

• The company reported quarterly net income of $131 million.

• Illumina Inc shares had fallen by 3.8% this quarter and lost 42.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3.6% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy," 13 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Illumina Inc is $111.00

This summary was machine generated from LSEG data May 9 at 02:40 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)